CARBYLAN THERAPEUTICS INC's ticker is CBYL and the CUSIP is 141384107.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $2,000 | -33.3% | 5,075 | 0.0% | 0.00% | – |
Q2 2016 | $3,000 | -94.3% | 5,075 | -93.8% | 0.00% | – |
Q1 2016 | $53,000 | -82.3% | 81,740 | -1.4% | 0.00% | – |
Q4 2015 | $300,000 | +2.7% | 82,935 | +1.6% | 0.00% | – |
Q3 2015 | $292,000 | -46.8% | 81,656 | +6.4% | 0.00% | – |
Q2 2015 | $549,000 | – | 76,718 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 1,178,941 | $8,429,000 | 0.45% |
SPHERA FUNDS MANAGEMENT LTD. | 400,000 | $2,860,000 | 0.28% |
PURA VIDA INVESTMENTS, LLC | 40,000 | $276,000 | 0.14% |
Omega Advisors Inc. | 100,000 | $715,000 | 0.01% |
PUTNAM INVESTMENTS LLC | 634,780 | $4,539,000 | 0.01% |
Pentwater Capital Management LP | 225,000 | $1,609,000 | 0.01% |
Alyeska Investment Group, L.P. | 199,736 | $1,428,000 | 0.01% |
PANAGORA ASSET MANAGEMENT INC | 207,158 | $1,481,000 | 0.01% |
FRANKLIN RESOURCES INC | 1,524,100 | $10,897,000 | 0.01% |
PRICE T ROWE ASSOCIATES INC /MD/ | 2,803,300 | $20,044,000 | 0.00% |